NCT06258642 2025-08-20Irinotecan Liposome Combined With Anlotinib as Second-line Regimen for SCLCFudan UniversityPhase NA Recruiting39 enrolled
NCT06188650 2024-01-03The Efficacy and Safety of Drug Loaded Microsphere Bronchial Artery Chemoembolization (DEB-BACE) Combined With Anlotinib and Adebelimumab in the Third Line Treatment of Advanced NSCLC: a Prospective, Single Arm, Single Center, Exploratory Clinical StudyNingbo Medical Center Lihuili HospitalPhase NA Recruiting30 enrolled